Jackson Square Capital’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,737
Closed -$535K 122
2023
Q3
$535K Sell
5,737
-32,593
-85% -$3.67M 0.21% 76
2023
Q2
$4.93M Buy
38,330
+2,686
+8% +$325K 1.98% 16
2023
Q1
$4.14M Sell
35,644
-1,715
-5% -$192K 1.85% 21
2022
Q4
$4.23M Buy
37,359
+4,888
+15% +$537K 1.99% 14
2022
Q3
$2.62M Sell
32,471
-209
-0.6% -$17.7K 1.28% 25
2022
Q2
$2.44M Buy
32,680
+13,396
+69% +$1.22M 1.03% 30
2022
Q1
$2.47M Buy
19,284
+2,256
+13% +$247K 0.77% 43
2021
Q4
$2.29M Buy
17,028
+256
+2% +$36.8K 0.66% 47
2021
Q3
$2.29M Buy
16,772
+4
+0% +$504 0.75% 42
2021
Q2
$1.79M Sell
16,768
-8,548
-34% -$821K 0.58% 54
2021
Q1
$2.27M Sell
25,316
-1,468
-5% -$138K 0.87% 41
2020
Q4
$2.48M Sell
26,784
-5,584
-17% -$499K 0.95% 37
2020
Q3
$3.34M Sell
32,368
-3,148
-9% -$329K 1.47% 25
2020
Q2
$3.6M Buy
35,516
+5,176
+17% +$463K 1.82% 17
2020
Q1
$2.04M Buy
30,340
+7,236
+31% +$450K 1.59% 22
2019
Q4
$1.26M Buy
+23,104
New +$1.1M 0.73% 49

Other funds holding DXCM

Jackson Square Capital's DXCM Position: Q4 2023 in Review

Jackson Square Capital sold out of DexCom (DXCM) in Q4 2023, closing a stake of 5,737 shares — an estimated $535K sold.

Jackson Square Capital first reported a position in DXCM in Q4 2019 and held it in 16 quarters. The position peaked at $4.93M in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Jackson Square Capital reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Jackson Square Capital sold 5,737 DexCom shares in Q4 2023, an estimated $535K.
  • Jackson Square Capital first reported a position in DexCom in Q4 2019 and held it in 16 quarters.
  • Jackson Square Capital's DexCom position peaked at $4.93M in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Jackson Square Capital's 13F filing for Q4 2023, filed 9 Jan 2024.